SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today an ...
Hosted on MSN6d
CathWorks completes enrolment in CAD treatment system trialCathWorks has completed the enrolment for a randomised controlled trial (RCT), evaluating the FFRangio system in diagnosing and treating coronary artery disease (CAD). The Advancing Cath Lab Results ...
CathWorks announced today the successful completion of enrollment of the Advancing Cath Lab Results with FFRangio Coronary Physiology Assessment randomized controlled trial.
Understanding myocardial blood flow (MBF) has become increasingly crucial in managing coronary artery disease (CAD ... and invasive tests like heart catheterization. In Dr. Johnson’s case ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback